In the present study, we found that TBK1 is highly expressed mainly in mesenchymal phenotype cholangiocarcinoma tissues, and exerts a critical role in maintaining the tumor-promoting function indicating that TBK1 is also a potential therapeutic target for CCA. This evidence concerns the gene TBK1 and cholangiocarcinoma.